Topic: ASCO New Vision For Cancer Research in the Next 10 Years

Hi,
I try to find a easier version for all of us to understand the  Nov. 4,2011 ASCO announcement  of  their goal for the future cancer research in the next 10 years.
here in the link.
http://www.medscape.com/viewarticle/752949

if it doesn't work, just go to medscape.com;click clinical trial on the top bar in the middle,then look for in the box "ASCO Unveils New Vision for Transforming Cancer Research".

In short,
1.Expanding health information technology to become more patient  and researcher friendly in the next 3-5 years; instead of paper , charts and separate computer records, it will be centralized. when go for a 2nd opinion in different institutions,patients do not need to bring records from separated sources to see the doctors;instead just bring your medical card.  We are behind other countries on this front.
2. ASCO will focus on targeted therapies that is driven by the understanding of cancer biology and the advent of new technologies; will coordinate different drug companies as well as researchers to combine their efforts to produce faster,better and more effective in the development of new drugs and treatments;will coordinate FDA,National Cancer Institute and others to harmonize their regulations for faster approval of treatments plan and risk aversion for the patients who experienced unwanted side effects.
God bless.

Please know that my personal opinion is not intended nor implied to be a substitute for professional medical advice. If  provided, information are for educational purposes.Consult doctor is a MUST for changing of treatment plans.

Re: ASCO New Vision For Cancer Research in the Next 10 Years

Percy....thank you for posting this.  Some hospitals are still lagging behind in the electronic record keeping but, without a doubt it is the future of healthcare in this country also. 
The revamping of the entire medical system is receiving much attention.  It also includes the newer approach to clinical trials in that those committees responsible for approval of trials have been combined and streamlined.  What I have noticed though that we are experiencing a lull in the production of new medications developed within the pharmaceutical industry. 
This may be of interest  http://www.cancer.gov/ncicancerbulletin/011111/page2

THIS INFORMATION IS NOT INTENDED NOR IMPLIED TO BE A SUBSTITUTE FOR PROFESSIONAL MEDICAL ADVICE. YOU SHOULD ALWAYS SEEK THE ADVICE OF YOUR PHYSICIAN OR OTHER QUALIFIED HEALTH CARE PROVIDER